US Stock MarketDetailed Quotes
ENZ Enzo Biochem
- 1.130
- 0.0000.00%
Close Nov 4 16:00 ET
59.04MMarket Cap-2215P/E (TTM)
1.145High1.090Low280.25KVolume1.130Open1.130Pre Close315.71KTurnover0.70%Turnover RatioLossP/E (Static)52.24MShares1.50052wk High1.05P/B45.44MFloat Cap0.99052wk Low--Dividend TTM40.21MShs Float114.354Historical High--Div YieldTTM4.87%Amplitude0.990Historical Low1.126Avg Price1Lot Size
Enzo Biochem Key Stats
Quarterly+Annual
YOY
| (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 28.98%-26.26M | 93.63%-1.09M | 43.37%-2.86M | -44.21%-8.94M | -53.85%-13.37M | -122.88%-36.98M | -87.77%-17.03M | -496.69%-5.05M | -883.81%-6.2M | -43.85%-8.69M |
| Net income from continuing operations | -228.54%-26.08M | -123.30%-13.38M | 80.11%-3.02M | 72.96%-3.06M | 37.79%-6.62M | 211.10%20.29M | 781.02%57.43M | -212.88%-15.19M | -326.37%-11.32M | -358.60%-10.64M |
| Operating gains losses | 106.93%116K | -9.27%-648K | 240.11%524K | 51.01%-730K | 23.88%970K | -150.12%-1.67M | -320.45%-593K | -116.28%-374K | -445.71%-1.49M | 128.95%783K |
| Depreciation and amortization | -52.57%1.27M | -34.32%398K | -47.99%337K | -57.35%267K | -66.33%270K | -5.13%2.68M | -12.05%606K | -11.48%648K | -11.21%626K | 14.41%802K |
| Other non cash items | 101.34%1.1M | --554K | --1.1M | ---882K | --328K | ---81.81M | ---- | ---- | ---- | ---- |
| Change In working capital | -144.48%-8.25M | 82.03%8.44M | -115.99%-1.43M | -209.18%-5.76M | -3,409.23%-9.51M | 371.51%18.56M | 307.71%4.64M | 725.16%8.92M | 1,660.06%5.27M | 94.93%-271K |
| -Change in receivables | -50.78%2.48M | -99.94%2K | 1.24%1.22M | -215.51%-767K | 18,454.55%2.02M | 487.45%5.03M | 1,134.24%3.17M | -66.17%1.21M | 116.57%664K | 99.02%-11K |
| -Change in inventory | 426.35%1.09M | 206.82%454K | 10.72%444K | -384.34%-236K | 208.91%428K | 87.79%-334K | 8.21%-425K | 137.76%401K | 6.41%83K | 69.51%-393K |
| -Change in prepaid assets | 38.10%145K | 118.71%233K | -31.85%184K | -249.28%-618K | -48.05%346K | 108.94%105K | 7.98%-1.25M | 147.87%270K | -27.62%414K | 289.47%666K |
| -Change in payables and accrued expense | -187.00%-11.97M | 147.29%7.75M | -146.54%-3.28M | -200.58%-4.14M | -2,208.26%-12.3M | 945.88%13.75M | 565.68%3.13M | 914.93%7.04M | 36.20%4.11M | 82.85%-533K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 28.98%-26.26M | 93.63%-1.09M | 43.37%-2.86M | -44.21%-8.94M | -53.85%-13.37M | -122.88%-36.98M | -87.77%-17.03M | -496.69%-5.05M | -883.81%-6.2M | -43.85%-8.69M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 80.25%-545K | 78.53%-123K | 78.53%-143K | 97.12%-25K | 61.04%-254K | -110.94%-2.76M | -55.28%-573K | -102.39%-666K | 29.98%-869K | 38.55%-652K |
| Capital expenditure reported | 80.25%-545K | 78.53%-123K | 78.53%-143K | 97.12%-25K | 61.04%-254K | 20.51%-2.76M | -55.28%-573K | 22.20%-666K | 28.42%-869K | 36.88%-652K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -100.55%-545K | -100.12%-123K | 78.53%-143K | 97.12%-25K | 61.04%-254K | 292.42%98.98M | 27,516.53%101.17M | -102.39%-666K | 29.98%-869K | 38.55%-652K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -272.71%-4.19M | 14.88%-3.61M | -101.34%-44K | 64.52%-22K | -445.26%-518K | -366.80%-1.13M | -4,316.67%-4.24M | 10,654.84%3.27M | -8.77%-62K | -66.67%-95K |
| Net issuance payments of debt | -227.38%-3.72M | 14.82%-3.61M | -101.14%-37K | 64.52%-22K | 46.32%-51K | -322.30%-1.14M | -4,313.54%-4.24M | 5,622.03%3.26M | -8.77%-62K | -66.67%-95K |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --386K | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | ---- | ---- | ---- | -50.00%14K | --0 | ---- | ---- | ---- |
| Net other financing activities | -21.85%-474K | --0 | ---7K | --0 | ---467K | ---389K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -272.71%-4.19M | 14.88%-3.61M | -101.34%-44K | 64.52%-22K | -445.26%-518K | -366.80%-1.13M | -4,316.67%-4.24M | 10,654.84%3.27M | -8.77%-62K | -66.67%-95K |
| Net cash flow | ||||||||||
| Beginning cash position | 268.86%83.37M | 1,473.68%57.16M | 895.06%60.24M | 426.89%69.21M | 268.86%83.37M | 58.35%22.6M | -88.70%3.63M | 17.35%6.05M | 84.84%13.14M | 58.35%22.6M |
| Current changes in cash | -150.92%-31M | -106.03%-4.82M | -24.55%-3.05M | -26.03%-8.99M | -49.85%-14.15M | 625.44%60.88M | 937.92%79.9M | -109.06%-2.45M | -269.76%-7.13M | -31.83%-9.44M |
| Effect of exchange rate changes | 95.41%-5K | 120.65%32K | -238.46%-36K | -60.42%19K | 28.57%-20K | -73.02%-109K | -2,037.50%-155K | 157.78%26K | 352.63%48K | -300.00%-28K |
| End cash Position | -37.18%52.37M | -37.18%52.37M | 1,473.68%57.16M | 895.06%60.24M | 426.89%69.21M | 268.86%83.37M | 268.86%83.37M | -88.70%3.63M | 17.35%6.05M | 84.84%13.14M |
| Free cash flow | 32.54%-26.8M | 93.14%-1.21M | 47.47%-3.01M | -26.83%-8.96M | -45.83%-13.63M | -98.07%-39.74M | -86.50%-17.6M | -235.88%-5.72M | -283.24%-7.07M | -32.07%-9.35M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data